Drive corporate/ portfolio strategy across functionsNew product planning, life cycle management and integrationInput to asset strategy and resource/investment allocation

Global Asset lead for Zynlonta for Diffuse Large B-Cell Lymphoma (DLBCL); leading global cross-functional Core Asset Team with focus on asset strategy and launch

Leading a high performing team for insights-driven decision making and to strengthen our commercial capabilities across International region; driving two highly successful launches in Cystic Fibrosis- Strategic Decision Support; use Data/Analytics & Customer Insights for sustainable growth of our business- Digital Customer Engagement to embed omni-channel; pivot and transform the organisation - Build fit-for-future commercial tools and processes for better insights and efficiency- Transform Training with a clear strategy & roadmap on functional skills and capabilities- Embed Customer Curiosity mindset across International

Internal rotation/stretch assignment for Type 1 Diabetes cell therapy - understand the evolving T1DM treatment landscape, lead the payer insights and inform clinical development, access and commercialization strategy

Responsible for Soliris P&L across multiple ultra-rare indications - PNH, aHUS and 3 new indications due to launch over the coming years. Responsibilities include:- Develop strategic and tactical plan for the franchise- Product positioning and messaging- KOL strategy and management- Segmentation and targeting- Diagnostic testing and patient finding

Responsible for a new global function at Alexion to execute high priority strategic and operational initiatives driven by Executive Team and Board of Directors e.g. - Product launch and commercialization: new metabolic launch, and blueprint for future launches in ultra-rare space- Global market entry strategy: evolution of market presence, new geographies- Corporate Strategic Plan and Annual Business Planning- Life Cycle Management/Next Gen for Soliris- Search and evaluation of new assets

- Led 'Dare To Try', an enterprise-wide Innovation & Experimentation capability to drive change from the grassroots level- Implemented governance structure and processes for a large scale commercial re-structuring across Europe- Facilitated workshops using creative problem solving for oncology product launch, generics business planning, global tenders and regional customer marketing implementation - Developed channel planning approach for Europe – this includes supply policy, value-added services for products and patient data collection

- Led on Digital Marketing Acceleration program for Pfizer Europe & Canada, utilising digital channels including self and tele-detailing to engage with customers. This now forms the backbone of new organisational structure, with significant resources and investment committed to digital.- Led the primary care environment and landscape analysis for key trends/drivers. The output formed an integral part of corporate strategic plan as well as regional and brand plans.- Developed E-Health strategy for Primary Care; leveraging health diagnostic tools, real world patient data and remote monitoring solutions in the care-giving process. Presented the recommendations to EuCan leadership and these are now integrated into global PCBU priorities.

- Successfully implemented field force CRM program, specifically designed to support and drive new selling behaviours, for 16 countries across Europe (9000 users)- Led the pan-European business reporting initiative; defined the KPIs and key metrics to be used by sales leadership and brand colleagues for business planning- Led a x-BU task force for diagnostic study of Pfizer-Customer engagement in 16 countries within Europe. I presented the findings and recommendations to regional leadership, and these were taken forward resulting in significant cost savings for Pfizer Europe

- Business analysis for a large-scale CRM engagement for a global pharma major.- Conducted business development, technology consultancy and portfolio rationalization projects - Developed the solution framework for a tele-detailing offering for pharma sales organizations.

- Developed new business opportunities in API research, contract manufacturing and co-licensing in Europe - Liaised with strategic partners and regulatory authorities in Europe- Supported the CEO in identification and analysis of new business initiatives, capital investment and product pipeline

- Responsible for Enterprise Server Group (ESG) business of IBM- Driving sales in Enterprise solutions space by facilitating client solution design- Enabling the channel partners to drive growth and profitability